Page 1 of Clinical Trials for Histone Deacetylase Inhibitors, 343 Total Matches
- 1CompletedSafety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid TumoursLast Updated: November 25, 2011Condition(s): Solid Tumor
- 2RecruitingLast Updated: May 18, 2012Condition(s): Cutaneous T-cell Lymphoma; Histone Deacetylase Inhibitor; Lymphoma; Oncology
- 3TerminatedLast Updated: February 1, 2012Condition(s): Hodgkin's Lymphoma
- 4CompletedLast Updated: March 29, 2012Condition(s): Lymphoma
- 5RecruitingLast Updated: April 8, 2012Condition(s): Gastric Cancer; Histone Deacetylase Inhibitor
- 6TerminatedLast Updated: February 1, 2012Condition(s): Chronic Lymphocytic Leukemia
- 7CompletedLast Updated: November 25, 2011Condition(s): Hematological Disease; Lymphoid Malignancies
- 8CompletedLast Updated: January 31, 2012Condition(s): Myeloproliferative Diseases
- 9TerminatedLast Updated: July 20, 2011Condition(s): Breast Cancer
- 10Not yet recruitingLast Updated: March 1, 2012Condition(s): HDAC Activity
- 11RecruitingLast Updated: February 16, 2012Condition(s): Advanced Hematologic Malignancies
- 12RecruitingLast Updated: December 5, 2011Condition(s): Graft-Versus-Host Disease
- 13CompletedLast Updated: January 31, 2012Condition(s): Hodgkin's Lymphoma
- 14RecruitingLast Updated: February 22, 2012Condition(s): Chordoma
- 15RecruitingLast Updated: May 18, 2012Condition(s): Multiple Myeloma
- 16RecruitingLast Updated: April 19, 2012Condition(s): Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer
- 17CompletedLast Updated: April 17, 2012Condition(s): Relapsed or Refractory Multiple Myeloma
- 18Active, not recruitingLast Updated: September 12, 2011Condition(s): Advanced Solid Tumors
- 19Not yet recruitingLast Updated: April 20, 2012Condition(s): Multiple Myeloma
- 20RecruitingLast Updated: March 26, 2012Condition(s): Advanced Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Histone+Deacetylase+Inhibitors
